<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="595639" id="root" date="1997-05-19" xml:lang="en">
<title>UK: UK's Galen float seen raising 30 million stg.</title>
<headline>UK's Galen float seen raising 30 million stg.</headline>
<dateline>LONDON 1997-05-19</dateline>
<text>
<p>Northern-Irish pharmaceutical company Galen Holdings Plc said on Monday that it planned to float on the London Stock Exchange in early July.</p>
<p>Sources close to the company told Reuters that the flotation of just over a quarter of the group's capital was expected to raise around 30 million stg in new funds, valuing Galen at about 180 million stg.</p>
<p>Baring Brothers International Ltd is acting as sponsor and underwriter to the float, with Hoare Govett Corporate Finance Ltd appointed as stockbroker.</p>
<p>The pathfinder prospectus is due to be published in mid-June.</p>
<p>Galen is a long-established business, founded in 1968. In the year to September 31 1996 it posted pre-tax profits of 7.2 million stg on sales of 31.1 million.</p>
<p>The company, which employs 600 people, specialises in the manufacture and marketing of prescription drugs and intravenous and sterile solutions. It also carries out research into new ways of delivering drugs.</p>
<p>Galen also has operations to supply patient packs for clinical trials on behalf of major pharmaceutical companies and to synthesise complex pharmaceuticals and chemicals for other companies.</p>
<p>Galen chief executive officer John King said changes in the pharmaceutical industry were enhancing Galen's growth prospects.</p>
<p>&quot;Flotation is a significant step and will enable us to take full advantage of the opportunities available,&quot; he said.</p>
<p>--London Newsroom +44 171 542 7717</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="UK">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C14">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
  <code code="C17">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
  <code code="C171">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-19"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-05-19"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-05-19"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="LONDON"/>
<dc element="dc.creator.location.country.name" value="UK"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
